Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма - Лиза Хендриксон-Джек

Zhu. “Decline in semen quality among 30,636 young Chinese men from 2001 to 2015.” Fertility and Sterility 107, no. 1 (2017): 83–88; Irvine, Stewart, Elizabeth Cawood, David Richardson, Eileen MacDonald, and John Aitken. “Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years.” The BMJ 312, no. 7029 (1996): 467–471.

15. Kumar, Naina, and Amit Kant Singh. “Trends of male factor infertility, an important cause of infertility: a review of literature.” Journal of Human Reproductive Sciences 8, no. 4 (2015): 191–196.

Глава 11

1. Viergiver, Ellenmae, and W.T. Pommerenke. “Measurement of the cyclic variations in the quantity of cervical mucus and its correlation with basal temperature.” American Journal of Obstetrics and Gynecology 48, no. 3 (1944): 321–328.

2. Odeblad, Erik. “The discovery of different types of cervical mucus and the Billings Ovulation Method.” Bulletin of the Natural Family Planning Council of Victoria 21, no. 3 (1994): 14; Klaus, Hanna. “Natural family planning: a review.” Obstetrical & Gynecological Survey 37, no. 2 (1982): 4–6.

3. Odeblad, Erik. “The discovery of different types of cervical mucus and the Billings Ovulation Method.” Bulletin of the Natural Family Planning Council of Victoria 21, no. 3 (1994): 14.

4. Matus, Geraldine Ed. “Atypical Mucus Patterns Accompanying Ovulation.” Justisse HRHP Training Program. Justisse College. Accessed February 5, 2017. www.justisse.ca/index.php/college/courseware/page/1308.

5. Elkind-Hirsch, Karen E., Kathy Phillips, Sandra M. Bello, Milton McNicho, and Dominique de Ziegler. “Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the effect of clomiphene on the endometrium in oligo-ovulatory women.” Human Reproduction 17, no. 2 (2002): 295; Glud, Eva, Susanne Kriiger Kjaer, Rebecca Troisi, and Louise A. Brinton. “Fertility drugs and ovarian cancer.” Epidemiologic Reviews 20, no. 2 (1998): 238.

6. Van der Merwe, J.V. “The effect of clomiphene and conjugated oestrogens on cervical mucus.” South African Medical Journal 60, no. 9 (1981): 347-349; Massai, Maria Rebecca, Dominique de Ziegler, Valerie Lesobre, Christine Bergeron, René Frydman, and Philippe Bouchard. “Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment.” Fertility and Sterility 59, no. 6 (1993): 1179–1186; Acharya, U., D.S. Irvine, M.P.R. Hamilton, and A.A. Templeton. “The effect of three anti-oestrogen drugs on cervical mucus quality and in-vitro sperm – cervical mucus interaction in ovulatory women.” Human Reproduction 8, no. 3 (1993): 437–441; Roumen, F.J. “Decreased quality of cervix mucus under the influence of clomiphene: a meta-analysis.” Nederlands Tijdschrift voor Geneeskunde 141, no. 49 (1997): 2401–2405.

7. Randall, John M., and Allan Templeton. “Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles.” Fertility and Sterility 56, no. 3 (1991): 467–468.

8. Там же.

9. Там же, 468.

10. Oktay, Kutluk, Erkan Buyuk, Natalie Libertella, Munire Akar, and Zev Rosenwaks. “Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.” Journal of Clinical Oncology 23, no. 19 (2005): 4347–4353; Oktay, K., E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks. “Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.” Human Reproduction 18, no. 1 (2003): 90–95; Acharya, U., D.S. Irvine, M.P.R. Hamilton, and A.A. Templeton. “The effect of three anti-oestrogen drugs on cervical mucus quality and in-vitro sperm – cervical mucus interaction in ovulatory women.” Human Reproduction 8, no. 3 (1993): 440.

11. Massai, Maria Rebecca, Dominique de Ziegler, Valerie Lesobre, Christine Bergeron, René Frydman, and Philippe Bouchard. “Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment.” Fertility and Sterility 59, no. 6 (1993): 1179–1186.

12. Asemi, Zatollah, Zahra Vahedpoor, Mehri Jamilian, Fereshteh Bahmani, and Ahmad Esmaillzadeh. “Effects of long-term folate supplementation on metabolic status and regression of cervical intraepithelial neoplasia: a randomized, double– blind, placebo-controlled trial.” Nutrition 32, no. 6 (2016): 681–686.

13. International Collaboration of Epidemiological Studies of Cervical Cancer. “Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies.” The Lancet 370, no. 9599 (2007): 1609–1621; Smith, Jennifer S., Jane Green, Amy Berrington De Gonzalez, Paul Appleby, Julian Peto, Martyn Plummer, Silvia Franceschi, and Valerie Beral. “Cervical cancer and use of hormonal contraceptives: a systematic review.” The Lancet 361, no. 9364 (2003): 1159–1167; Madeleine, Margaret M., Janet R. Daling, Stephen M. Schwartz, Katherine Shera, Barbara McKnight, Joseph J. Carter, Gregory C. Wipf. “Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.” Cancer Epidemiology and Prevention Biomarkers 10, no. 3 (2001): 171–177.

14. Braaten, Kari P., and Marc R. Laufer. “Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine.” Reviews in Obstetrics and Gynecology 1, no. 1 (2008): 2–10; Centers for Disease Control and Prevention. Genital HPV Infection Fact Sheet. Rockville, MD: CDC National Prevention Information Network, 2004.

15. Marks, Morgan, Patti E. Gravitt, Swati B. Gupta, Kai-Li Liaw, Amha Tadesse, Esther Kim, Chailert Phongnarisorn. “Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand.” Journal of Infectious Diseases 204, no. 10 (2011): 1505–1513.

16. Zhao, W., M. Hao, Y. Wang, N. Feng, Z. Wang, W. Wang, J. Wang, and L. Ding. “Association between folate status and cervical intraepithelial neoplasia.” European Journal of Clinical Nutrition 70, no. 7 (2016): 837–842; Piyathilake, Chandrika J., Maurizio Macaluso, Michelle M. Chambers, Suguna Badiga, Nuzhat R. Siddiqui, Walter C. Bell, Jeffrey C. Edberg, Edward E. Partridge, Ronald D. Alvarez, and Gary L. Johanning. “Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation – associated risk of developing higher grades of CIN.” Cancer Prevention Research 7, no. 11 (2014): 1128–1137; Shimizu, H., C. Nagata, S. Komatsu, N. Morita, H. Higashiiwai, N. Sugahara, and S. Hisamichi. “Decreased serum retinol levels in women with cervical dysplasia.” British Journal of Cancer 73, no. 12 (1996): 1600.

17. Butterworth, C.E., Kenneth D. Hatch, Hazel Gore, Helmut Mueller, and Carlos L. Krumdieck. “Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives.” The